TGFB1 and asthma: Furthermore, TGF-β1 expression in airway eosinophils and decreased concentration of TGF-β1 in bronchoalveolar lavage fluid were also reduced by Mepolizumab treatment in asthma patients, suggesting the possible role of Mepolizumab in improving tissue remodeling in type 2 CRS [129].